NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,009 filers reported holding NOVARTIS A G in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $204,000 | -10.5% | 2,153 | -13.7% | 0.02% | -10.5% |
Q2 2019 | $228,000 | -13.0% | 2,496 | -8.4% | 0.02% | -13.6% |
Q1 2019 | $262,000 | +1.2% | 2,724 | -9.9% | 0.02% | -8.3% |
Q4 2018 | $259,000 | -10.1% | 3,024 | -9.7% | 0.02% | 0.0% |
Q3 2018 | $288,000 | +24.1% | 3,347 | +9.0% | 0.02% | +9.1% |
Q2 2018 | $232,000 | -2.1% | 3,071 | +4.6% | 0.02% | -4.3% |
Q1 2018 | $237,000 | -37.5% | 2,936 | -34.9% | 0.02% | -37.8% |
Q4 2017 | $379,000 | +53.4% | 4,511 | +56.6% | 0.04% | +32.1% |
Q3 2017 | $247,000 | -85.9% | 2,881 | -87.0% | 0.03% | -88.8% |
Q3 2016 | $1,750,000 | +33.9% | 22,159 | +39.9% | 0.25% | +26.1% |
Q2 2016 | $1,307,000 | +312.3% | 15,836 | +329.3% | 0.20% | +282.7% |
Q4 2015 | $317,000 | +14.0% | 3,689 | +21.8% | 0.05% | +4.0% |
Q3 2015 | $278,000 | +8.6% | 3,028 | +16.2% | 0.05% | +16.3% |
Q2 2015 | $256,000 | – | 2,606 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |